Cancer News and Research

Latest Cancer News and Research

AI predicts cell responses to drugs and genetic changes

Controlling the state of a cell in a desired direction is one of the central challenges in life sciences, including drug development, cancer treatment, and regenerative medicine.

16 Oct 2025

LassoESM accelerates discovery of therapeutic peptides

In the hunt for new therapeutics for cancer and infectious diseases, lasso peptides prove to be a catch.

16 Oct 2025

New vaccine label offers real-time heat exposure detection

A color-changing label could help prevent millions of vaccine doses from going to waste, say scientists from the University of Surrey. The innovation, now being commercialized through a partnership with MM PACKAGING GmbH (MM) Group and leading materials specialists Advanced Material Development Ltd (AMD), provides a low-cost and reliable way to show whether vaccines have been exposed to damaging heat.

16 Oct 2025

Family conflict and peer pressure drive teen mental health risks

A new study from researchers at Washington University School of Medicine in St. Louis provides some answers.

16 Oct 2025

Cancer hijacks embryonic gene editors to fuel growth

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors", that control how those genes are read.

16 Oct 2025

New insights into how bacteria can drive treatment resistance in oral and colorectal cancer

Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer.

16 Oct 2025

NYU Langone sets the standard for organ transplant care

The NYU Langone Transplant Institute is the state's top-quality program for liver and kidney transplantation and has some of the fastest heart and lung transplant rates in the nation, according to the latest national data.

16 Oct 2025

Smartphone app for muscle relaxation reduces migraine disability in ED patients

A smartphone app for muscle relaxation significantly reduced migraine-related disability in patients visiting the emergency department, a new study shows.

16 Oct 2025

Blocking key protein restores healthy lung function and reduces fibrosis in mice

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body.

16 Oct 2025

Caring-healing approaches strengthen resilience and emotional recovery in cancer survivors

As cancer survivorship rises, many people living with or beyond cancer face lasting physical and emotional challenges – particularly anxiety and depression, which affect about 30% of this population. Emotional distress is often unspoken, leading to fear, despair, and diminished quality of life.

16 Oct 2025

New personalized therapy boosts tamoxifen effectiveness in breast cancer patients

Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) has now developed a new therapy in a clinical study that tailors hormone treatment for breast cancer to the individual patient.

16 Oct 2025

Thymic health found to predict immunotherapy success in cancer patients

The health of the thymus - a key part of the body's immune system - is associated with cancer patients' outcomes to immune checkpoint inhibitor treatment, according to a ground-breaking international study reported at ESMO 2025.

16 Oct 2025

Researchers discover new genetic cause of hereditary optic atrophy

A research team from the Medical University of Vienna and the Medical University of Graz has discovered a previously unknown genetic cause of hereditary optic atrophy, a degenerative disease of the optic nerve associated with gradual loss of vision.

16 Oct 2025

Study uncovers mechanisms regulating the cell’s primary cilia

Prof. Dr. Elif Nur Fırat Karalar from Koç University's Department of Molecular Biology and Genetics and her team have uncovered the molecular mechanisms responsible for regulating a structure that plays a critical role in how cells communicate with their environment.

16 Oct 2025

Uncovering a molecular weakness in Ewing sarcoma for targeted therapy

A research team at the Seville Biomedical Institute (IBis) has identified a new molecular mechanism that explains the high sensitivity of Ewing sarcoma (an aggressive bone cancer that mainly affects children and adolescents) to certain chemotherapy drugs, such as irinotecan.

16 Oct 2025